Insider Buy/Sell Details for the Biotechnology Industry — October 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (71)
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
25,124
Price
$11.75
Total Value
$295.09K
Shares Held After
1,624,789
% of Holdings
1.5%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
66,411
Price
$1.77
Total Value
$117.41K
Shares Held After
3,036,411
% of Holdings
2.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
9,606
Price
$2.38
Total Value
$22.86K
Shares Held After
3,011,749
% of Holdings
0.3%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
2,510
Price
$12.11
Total Value
$30.39K
Shares Held After
1,599,665
% of Holdings
0.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
6,234
Price
$2.38
Total Value
$14.84K
Shares Held After
3,002,143
% of Holdings
0.2%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
8,000
Price
$2.98
Total Value
$23.84K
Shares Held After
1,054,003
% of Holdings
0.8%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$8.07
Total Value
$403.52K
Shares Held After
1,187,000
% of Holdings
4.2%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
31,675
Price
$0.16
Total Value
$5.07K
Shares Held After
189,747
% of Holdings
16.7%
Rapport Therapeutics, Inc. (RAPP)
Sanchez Ramiro — Director
Shares
3,600
Price
$27.35
Total Value
$98.48K
Shares Held After
3,600
% of Holdings
100.0%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
40,000
Price
$11.04
Total Value
$441.46K
Shares Held After
1,597,155
% of Holdings
2.5%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
12,175
Price
$9.68
Total Value
$117.81K
Shares Held After
1,557,155
% of Holdings
0.8%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
21,390
Price
$1.93
Total Value
$41.19K
Shares Held After
2,970,000
% of Holdings
0.7%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
5,800
Price
$2.40
Total Value
$13.92K
Shares Held After
2,995,909
% of Holdings
0.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.19
Total Value
$818.52K
Shares Held After
1,137,000
% of Holdings
8.8%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
31,250
Price
$0.16
Total Value
$5.09K
Shares Held After
158,072
% of Holdings
19.8%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
8,000
Price
$2.72
Total Value
$21.76K
Shares Held After
680,000
% of Holdings
1.2%
Rapport Therapeutics, Inc. (RAPP)
PAUL STEVEN M — Director
Shares
35,714
Price
$27.28
Total Value
$974.28K
Shares Held After
77,380
% of Holdings
46.2%
Rapport Therapeutics, Inc. (RAPP)
MARAGANORE JOHN — Director
Shares
1,172
Price
$26.92
Total Value
$31.55K
Shares Held After
9,411
% of Holdings
12.5%
Rapport Therapeutics, Inc. (RAPP)
MARAGANORE JOHN — Director
Shares
8,239
Price
$26.38
Total Value
$217.34K
Shares Held After
8,239
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Silva Paul M — Director
Shares
3,680
Price
$27.07
Total Value
$99.64K
Shares Held After
3,680
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Young Wendy B. — Director
Shares
3,789
Price
$26.39
Total Value
$99.99K
Shares Held After
13,289
% of Holdings
28.5%
Rapport Therapeutics, Inc. (RAPP)
Ignelzi Troy A. — Chief Financial Officer
Shares
5,500
Price
$26.10
Total Value
$143.55K
Shares Held After
15,500
% of Holdings
35.5%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
331,979
Price
$1.66
Total Value
$550.69K
Shares Held After
7,447,000
% of Holdings
4.5%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
254,342
Price
$1.60
Total Value
$405.73K
Shares Held After
7,115,021
% of Holdings
3.6%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
220
Price
$2.37
Total Value
$521.40
Shares Held After
2,990,109
% of Holdings
0.0%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
4,256
Price
$1.88
Total Value
$8.00K
Shares Held After
2,948,610
% of Holdings
0.1%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
336,528
Price
$1.51
Total Value
$507.01K
Shares Held After
6,860,679
% of Holdings
4.9%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
18,279
Price
$2.33
Total Value
$42.59K
Shares Held After
2,989,889
% of Holdings
0.6%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
12,790
Price
$2.34
Total Value
$29.93K
Shares Held After
2,971,610
% of Holdings
0.4%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,086
Price
$1.32
Total Value
$1.43K
Shares Held After
956,580
% of Holdings
0.1%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
300
Price
$0.95
Total Value
$285.00
Shares Held After
385,385
% of Holdings
0.1%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
118,185
Price
$2.34
Total Value
$276.55K
Shares Held After
2,958,820
% of Holdings
4.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1
Price
$1.32
Total Value
$1.32
Shares Held After
955,494
% of Holdings
0.0%
X4 Pharmaceuticals, Inc (XFOR)
Craig Adam R — Director
Shares
4,600
Price
$2.58
Total Value
$11.88K
Shares Held After
333,251
% of Holdings
1.4%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
36,347
Price
$1.89
Total Value
$68.76K
Shares Held After
2,944,354
% of Holdings
1.2%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
200
Price
$0.95
Total Value
$190.00
Shares Held After
385,085
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
23,485
Price
$1.95
Total Value
$45.69K
Shares Held After
2,908,007
% of Holdings
0.8%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
984
Price
$1.32
Total Value
$1.30K
Shares Held After
955,493
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
11,233
Price
$1.93
Total Value
$21.73K
Shares Held After
2,884,522
% of Holdings
0.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
170,000
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,451
Price
$85.00
Total Value
$208.33K
Shares Held After
169,900
% of Holdings
1.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,449
Price
$84.07
Total Value
$205.89K
Shares Held After
167,449
% of Holdings
1.5%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
745,588
% of Holdings
0.0%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$85.00
Total Value
$209.95K
Shares Held After
745,488
% of Holdings
0.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$84.07
Total Value
$207.65K
Shares Held After
743,018
% of Holdings
0.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
10,000
Price
$8.46
Total Value
$84.57K
Shares Held After
1,037,000
% of Holdings
1.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,021
Price
$1.33
Total Value
$10.67K
Shares Held After
954,509
% of Holdings
0.8%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.35
Total Value
$835.48K
Shares Held After
1,027,000
% of Holdings
9.7%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
564
Price
$1.33
Total Value
$750.12
Shares Held After
946,488
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
7,215
Price
$2.02
Total Value
$14.57K
Shares Held After
2,873,289
% of Holdings
0.3%
71 transactions